Novacyt S.A.
ALNOV.PA · PAR
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | €27,826 | €26,566 | €35,189 | €33,060 |
| - Cash | €0 | €0 | €30,453 | €32,939 |
| + Debt | €0 | €0 | €11,878 | €13,143 |
| Enterprise Value | €27,826 | €26,566 | €16,614 | €13,264 |
| Revenue | €4,897 | €4,897 | – | €5,161 |
| % Growth | 0% | – | – | – |
| Gross Profit | €3,254 | €3,254 | – | -€6,513 |
| % Margin | 66.4% | 66.4% | – | -126.2% |
| EBITDA | -€2,560 | -€2,560 | – | -€12,022 |
| % Margin | -52.3% | -52.3% | – | -232.9% |
| Net Income | -€3,171 | -€3,171 | – | -€8,850 |
| % Margin | -64.8% | -64.8% | – | -171.5% |
| EPS Diluted | -0.048 | -0.048 | – | -0.13 |
| % Growth | 0% | – | – | – |
| Operating Cash Flow | -€2,737 | -€2,737 | -€439 | -€4,544 |
| Capital Expenditures | -€91 | -€91 | -€549 | -€369 |
| Free Cash Flow | -€2,828 | -€2,828 | -€988 | -€4,913 |